دورية أكاديمية
Alterations in the CD56 - and CD56 + T Cell Subsets during COVID-19.
| العنوان: | Alterations in the CD56 - and CD56 + T Cell Subsets during COVID-19. |
|---|---|
| المؤلفون: | Vavilova JD; Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia., Ustiuzhanina MO; Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.; Center of Life Sciences, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia., Boyko AA; Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia., Streltsova MA; Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia., Kust SA; Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia., Kanevskiy LM; Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia., Iskhakov RN; Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia., Sapozhnikov AM; Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia., Gubernatorova EO; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia., Drutskaya MS; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.; Division of Immunobiology and Biomedicine, Sirius University of Science and Technology, Sirius, Krasnodarsky Krai, 354349 Sochi, Russia., Bychinin MV; Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies FMBA of Russia, 115682 Moscow, Russia., Novikova ON; Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies FMBA of Russia, 115682 Moscow, Russia., Sotnikova AG; Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies FMBA of Russia, 115682 Moscow, Russia., Yusubalieva GM; Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies FMBA of Russia, 115682 Moscow, Russia.; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia., Baklaushev VP; Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies FMBA of Russia, 115682 Moscow, Russia.; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia., Kovalenko EI; Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia. |
| المصدر: | International journal of molecular sciences [Int J Mol Sci] 2023 May 20; Vol. 24 (10). Date of Electronic Publication: 2023 May 20. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI, [2000- |
| مواضيع طبية MeSH: | CD8-Positive T-Lymphocytes* , COVID-19*/metabolism, Humans ; T-Lymphocyte Subsets ; Killer Cells, Natural ; Cell Differentiation |
| مستخلص: | The effectiveness of the antiviral immune response largely depends on the activation of cytotoxic T cells. The heterogeneous group of functionally active T cells expressing the CD56 molecule (NKT-like cells), that combines the properties of T lymphocytes and NK cells, is poorly studied in COVID-19. This work aimed to analyze the activation and differentiation of both circulating NKT-like cells and CD56 - T cells during COVID-19 among intensive care unit (ICU) patients, moderate severity (MS) patients, and convalescents. A decreased proportion of CD56 + T cells was found in ICU patients with fatal outcome. Severe COVID-19 was accompanied by a decrease in the proportion of CD8 + T cells, mainly due to the CD56 - cell death, and a redistribution of the NKT-like cell subset composition with a predominance of more differentiated cytotoxic CD8 + T cells. The differentiation process was accompanied by an increase in the proportions of KIR2DL2/3 + and NKp30 + cells in the CD56 + T cell subset of COVID-19 patients and convalescents. Decreased percentages of NKG2D + and NKG2A + cells and increased PD-1 and HLA-DR expression levels were found in both CD56 - and CD56 + T cells, and can be considered as indicators of COVID-19 progression. In the CD56 - T cell fraction, increased CD16 levels were observed in MS patients and in ICU patients with lethal outcome, suggesting a negative role for CD56 - CD16 + T cells in COVID-19. Overall, our findings suggest an antiviral role of CD56 + T cells in COVID-19. |
| References: | J Gen Intern Med. 2020 May;35(5):1545-1549. (PMID: 32133578) Cell. 2022 Feb 3;185(3):493-512.e25. (PMID: 35032429) J Immunol. 2008 Apr 15;180(8):5327-34. (PMID: 18390714) Mol Biol. 2022;56(6):1028-1035. (PMID: 36532266) Cells. 2022 Oct 25;11(21):. (PMID: 36359755) Front Immunol. 2020 Oct 14;11:580237. (PMID: 33154753) Signal Transduct Target Ther. 2021 Sep 24;6(1):346. (PMID: 34561414) Immunology. 2014 Jun;142(2):258-68. (PMID: 24433347) J Immunol. 2009 Apr 1;182(7):4175-82. (PMID: 19299715) Cells. 2021 Nov 15;10(11):. (PMID: 34831404) Front Immunol. 2021 Feb 16;11:613882. (PMID: 33664730) Immunity. 2021 Jul 13;54(7):1578-1593.e5. (PMID: 34051147) Cell. 2020 Oct 1;183(1):158-168.e14. (PMID: 32979941) Blood Sci. 2020 Jul 25;2(3):76-78. (PMID: 35402822) Immunol Rev. 2009 May;229(1):114-25. (PMID: 19426218) Cell Mol Immunol. 2021 Oct;18(10):2325-2333. (PMID: 34413488) Clin Immunol. 2022 Dec;245:109177. (PMID: 36356848) Clin Immunol. 2020 Sep;218:108516. (PMID: 32574709) Nat Commun. 2020 Oct 16;11(1):5243. (PMID: 33067472) J Immunol. 2008 Feb 1;180(3):1979-90. (PMID: 18209097) Immunity. 2017 Mar 21;46(3):364-378. (PMID: 28329703) Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076) J Clin Med. 2022 Jun 27;11(13):. (PMID: 35806995) Clin Infect Dis. 2020 Jul 28;71(15):762-768. (PMID: 32161940) Eur J Immunol. 1994 Oct;24(10):2294-8. (PMID: 7925558) Front Immunol. 2016 Dec 19;7:616. (PMID: 28066426) J Pers Med. 2021 Dec 03;11(12):. (PMID: 34945761) Immunity. 2002 Jul;17(1):19-29. (PMID: 12150888) Hum Immunol. 2006 Nov;67(11):863-73. (PMID: 17145366) Int J Mol Sci. 2017 Aug 10;18(8):. (PMID: 28796199) Sci Rep. 2021 Jun 15;11(1):12606. (PMID: 34131192) Clin Immunol. 2021 Jan;222:108630. (PMID: 33189887) Emerg Microbes Infect. 2020 Dec;9(1):1123-1130. (PMID: 32475230) Int J Mol Sci. 2023 Jan 19;24(3):. (PMID: 36768315) Science. 2022 Apr 15;376(6590):eabi9591. (PMID: 35258337) Int J Mol Sci. 2022 Nov 24;23(23):. (PMID: 36498998) Curr Opin HIV AIDS. 2012 Jan;7(1):50-7. (PMID: 22134341) Front Immunol. 2017 Jul 24;8:892. (PMID: 28791027) Scand J Immunol. 2021 Feb;93(2):e12967. (PMID: 32875598) Front Immunol. 2022 Aug 08;13:931039. (PMID: 36003367) Science. 2020 Sep 4;369(6508):. (PMID: 32669297) Int J Mol Sci. 2017 Aug 02;18(8):. (PMID: 28767057) Nat Commun. 2020 Jul 8;11(1):3410. (PMID: 32641700) Signal Transduct Target Ther. 2020 Mar 27;5(1):33. (PMID: 32296069) Front Immunol. 2022 Dec 16;13:1066176. (PMID: 36591270) JCI Insight. 2020 Sep 3;5(17):. (PMID: 32706339) Am J Hematol. 2020 Jun;95(6):E131-E134. (PMID: 32129508) Cell Death Differ. 2022 Aug;29(8):1486-1499. (PMID: 35066575) Front Cell Infect Microbiol. 2019 Jun 13;9:207. (PMID: 31263684) Cell Mol Immunol. 2020 May;17(5):533-535. (PMID: 32203188) Viruses. 2022 Aug 28;14(9):. (PMID: 36146713) PLoS One. 2021 Dec 22;16(12):e0261727. (PMID: 34936686) Nat Rev Immunol. 2004 Mar;4(3):231-7. (PMID: 15039760) Immunol Lett. 2020 Sep;225:31-32. (PMID: 32569607) J Biol Chem. 2012 Jun 15;287(25):21067-81. (PMID: 22547068) Allergy. 2021 Sep;76(9):2866-2881. (PMID: 33884644) Br J Haematol. 2020 Oct;191(2):207-211. (PMID: 32679621) J Immunol. 2009 Jan 1;182(1):92-101. (PMID: 19109139) Front Immunol. 2020 May 01;11:827. (PMID: 32425950) J Clin Invest. 2020 Sep 1;130(9):4694-4703. (PMID: 32463803) Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):E5980-E5989. (PMID: 29895693) Sci Immunol. 2020 Jul 15;5(49):. (PMID: 32669287) J Leukoc Biol. 2010 Jan;87(1):107-16. (PMID: 19880576) J Clin Med. 2022 Jan 28;11(3):. (PMID: 35160150) Front Immunol. 2021 May 26;12:665329. (PMID: 34122423) Immunology. 2014 Jul;142(3):321-36. (PMID: 24428389) Eur J Immunol. 2021 Mar;51(3):672-681. (PMID: 33231295) J Virol. 2017 Mar 29;91(8):. (PMID: 28179527) Virol J. 2022 Nov 19;19(1):192. (PMID: 36403042) J Exp Med. 2020 Dec 7;217(12):. (PMID: 32886755) Blood. 2012 Oct 25;120(17):3455-65. (PMID: 22968455) Exp Gerontol. 2014 Jul;55:54-62. (PMID: 24703889) Theranostics. 2022 Jan 1;12(1):290-306. (PMID: 34987646) J Immunol. 2008 Sep 15;181(6):4219-28. (PMID: 18768879) Cells. 2020 Mar 21;9(3):. (PMID: 32245149) Cell Mol Immunol. 2020 May;17(5):541-543. (PMID: 32203186) Cell Rep. 2022 Mar 8;38(10):110503. (PMID: 35235832) Autoimmun Rev. 2020 Jul;19(7):102561. (PMID: 32376401) Rev Med Virol. 2020 Nov;30(6):1-9. (PMID: 32845568) Immunity. 2021 Jan 12;54(1):44-52.e3. (PMID: 33338412) Front Immunol. 2021 Mar 11;12:655934. (PMID: 33777054) J Immunol. 2000 Feb 1;164(3):1148-52. (PMID: 10640724) J Intensive Care. 2020 May 24;8:36. (PMID: 32483488) Nat Rev Immunol. 2018 Mar;18(3):153-167. (PMID: 28990585) Microbiol Spectr. 2022 Feb 23;10(1):e0084521. (PMID: 35196808) Nat Immunol. 2001 Mar;2(3):255-60. (PMID: 11224526) Nat Med. 2020 Oct;26(10):1636-1643. (PMID: 32839624) Int J Mol Sci. 2021 Dec 04;22(23):. (PMID: 34884936) Sci Immunol. 2020 Sep 28;5(51):. (PMID: 32989174) J Immunol. 2013 Aug 15;191(4):1625-36. (PMID: 23858032) |
| معلومات مُعتمدة: | 22-15-00503 Russian Science Foundation |
| فهرسة مساهمة: | Keywords: CD56+ T cells; COVID-19; HLA-DR; KIR2DL2/3; NKT-like cells; NKp30; PD1; T cells |
| تواريخ الأحداث: | Date Created: 20230527 Date Completed: 20230529 Latest Revision: 20230529 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC10219320 |
| DOI: | 10.3390/ijms24109047 |
| PMID: | 37240393 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1422-0067 |
|---|---|
| DOI: | 10.3390/ijms24109047 |